Zhanna Kravchuk Becomes the Chief Scientist of Darnitsa Pharmaceutical Company30 March 2020
Zhanna Kravchuk, Head of the Medical Department of Darnitsa Pharmaceutical Company has been appointed as the Chief Scientist of the Company.
The current times of global challenges require prompt solutions and the creation of a new powerful mechanism to combat the threat of the epidemic. For this reason, the Board of Directors of Darnitsa Group has decided to create the position of the Chief Scientist of Darnitsa.
Dmytro Shymkiv, Chairman of the Board of Directors of Darnitsa Group:
“Each of the world's leading pharmaceutical companies invests in science, research, and development, as they always look to the future. Given the COVID-19 crisis, the number of opportunities and requests for unconventional solutions is increasing with every passing day. Studying new drug options, analyzing therapies and developments, studying advanced world patents and developing our own, collaborating with leading scientists and healthcare professionals of the world – all of these things are the responsibility of the Chief Scientist who will work on the tasks of the Board of Directors of Darnitsa Group and interact with the task force of Darnitsa.”
Zhanna Kravchuk is a Candidate of Sciences (Biology). She has 20 years of professional experience in research, medical and regulatory areas. She worked and conducted research at the Institute of Cell Biology and Genetic Engineering of the National Academy of Sciences of Ukraine, the University of Neuchâtel, Switzerland, Jaime I University, Spain. For 12 years she worked in executive positions of the most famous national pharmaceutical companies, such as Darnitsa and Arterium, where she engaged in research and development, provided regulatory and medical support for the promotion of medicinal products in the Ukrainian and international markets. She has more than 50 scientific publications and is the author of 5 patents.
Over the last two years, under the leadership of Zhanna Kravchuk together with the team of the Medical Department Darnitsa developed, researched, got licensed and registered 25 new products in Ukraine. Another 13 products are at the registration stage.